FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/15/2025
Back to search
Official data from USPTO
CONCENTREX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CONCENTREX
ST13
US500000079384245Class
9, 42
Filing
79384245
Registration
7646608
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
04/03/2026
Trademark type
Word
Nice classes
9, 42
Filing date
09/26/2023
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
HUTCHISON, DAVID A
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Max Moskowitz OSTROLENK FABER LLP
Technical classification
Nice Classes
Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer platform for patient and doctor interaction in the field of schizophrenia; downloadable mobile software applications for accessing health information personalized health services and educational healthcare information in the field of schizophrenia; downloadable software and mobile applications as a medical device for treating psychological conditions in the field of schizophrenia; downloadable software and mobile applications being digital therapeutics for treating psychological conditions in the field of schizophrenia
Class 42
Medical and scientific research in the field of pharmaceutical preparations in the field of schizophrenia; providing medical and scientific research information in the field of pharmaceutical preparations in the field of schizophrenia
Publications
History of USPTO decisions and trademark events.
33 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/25/2025
FIMP
FINAL DISPOSITION PROCESSED
07/24/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/17/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/29/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/29/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/15/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
12/11/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
12/10/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/29/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/17/2024
PUBO
PUBLISHED FOR OPPOSITION
09/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/14/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
08/14/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/14/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
08/14/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/06/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
07/27/2024
RFNT
REFUSAL PROCESSED BY IB
04/24/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2024
RFRR
REFUSAL PROCESSED BY MPU
03/29/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/10/2024
CNRT
NON-FINAL ACTION WRITTEN
03/09/2024
DOCK
ASSIGNED TO EXAMINER
03/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
12/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/30/2023
Continuous trademark protection
Get notified about every new filing that threatens CONCENTREX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.